Stock Split News

BARCELONA, Spain--(BUSINESS WIRE)--Wallbox (NYSE: WBX) today announced that it is expected to implement a 20-for-1 reverse stock split of all classes of the Company’s ordinary shares. The reverse stock split is intended to bring the Company into compliance with the minimum bid price requirement set by the New York Stock Exchange (“NYSE”). Wallbox shareholders approved at the Company’s Annual General Meeting held on June 30, 2025 (“AGM”) a reverse stock split ratio within a range of 1-for-10 to...

SAN DIEGO--(BUSINESS WIRE)--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), announced today that, on July 7, 2025, the Company will implement a 1-for-3 reverse split of its common stock following approval at its Special Meeting of Stockholders held on June 23, 2025. The reverse stock split will be effective as of the morning of July 7, 2025, and the Company’s common stock will trade on a post-split basis at the beginning of trading on the same date under the existin...

WALTHAM, Mass.--(BUSINESS WIRE)--Pegasystems Inc. (NASDAQ: PEGA), The Enterprise Transformation Company™, announced that shareholders approved an increase in authorized shares at today's annual shareholder meeting to enable a two-for-one stock split to make the stock more accessible to a broader base of investors and employees. The two-for-one stock split will be issued after the close of business on June 20, 2025, and trading will begin on a split-adjusted basis on June 23, 2025. Following the...

PHILADELPHIA--(BUSINESS WIRE)--Armada Acquisition Corp. II (NASDAQ: AACIU) (the “Company”) announced today that, commencing June 24, 2025, holders of the 23,000,000 units sold in the Company’s initial public offering may elect to separately trade shares of the Company’s Class A ordinary shares and warrants included in the units. The Class A ordinary shares and warrants that are separated will trade on the Nasdaq Stock Market LLC (“Nasdaq”) under the symbols “AACI” and “AACIW”, respectively. No...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (OTC: SPRB) (“Spruce”), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, announced that it has received approval from The Nasdaq Stock Market LLC (“Nasdaq”) to resume trading of its common stock on the Nasdaq Capital Market subject to Spruce regaining compliance with Nasdaq’s minimum bid price requirement on or bef...

HOUSTON--(BUSINESS WIRE)--Stem, Inc. (NYSE: STEM) (the “Company” or “Stem”) today announced that it will implement a 1-for-20 reverse stock split of the issued and outstanding shares of the Company's common stock, effective at 12:01 a.m. Eastern Time on June 23, 2025 (the “Effective Time”), in order to regain compliance with the minimum average closing price requirement under the rules of the New York Stock Exchange (the “NYSE”). The Company's common stock is expected to begin trading on a reve...

LOS ANGELES--(BUSINESS WIRE)--System1, Inc. (NYSE: SST) (“System1” or the “Company”), an omnichannel customer acquisition marketing platform, previously announced on June 10, 2025, that the Company’s board of directors has approved a reverse stock split (the “Reverse Stock Split”) of all of its issued and outstanding Class A Common Stock, par value $0.0001 per share (“Class A Common Stock”) and Class C Common Stock, par value $0.0001 per share (“Class C Common Stock”, and together with the Clas...

LOS ANGELES--(BUSINESS WIRE)--System1, Inc. (NYSE: SST) (“System1” or the “Company”), an omnichannel customer acquisition marketing platform, today announced that its board of directors has approved a reverse stock split (the “Reverse Stock Split”) of its Class A Common Stock, par value $0.0001 per share (“Class A Common Stock”) and Class C Common Stock, par value $0.0001 per share (“Class C Common Stock”, and together with the Class A Common Stock, the “Common Stock”) at a ratio of 1-for-10. S...

WESTLAKE, Texas--(BUSINESS WIRE)--Schwab Asset Management announces reduction of operating expense ratios for 4 equity index ETFs and forward share splits on 6 Schwab mutual funds....

BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced a planned reverse stock split of its shares of common stock at a ratio of 1-for-6. The reverse stock split will take effect as of 12:01 a.m. ET, on Tuesday, June 10, 2025, and shares of Bone Biologics are expected to trade on a post-split basis on Nasdaq under the existing trading symbol, “BBLG,”...